BETHLEHEM, PA--(Marketwired - May 19, 2015) - B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced that it received U.S. Food and Drug Administration (FDA) ...
BETHLEHEM, PA--(Marketwired - Jul 11, 2016) - B. Braun Medical Inc., a leader in infusion therapy and pain management, announced today that it has launched its new 500mg Meropenem for Injection USP ...
BETHLEHEM, PA — B. Braun Medical Inc. has expanded its DUPLEX® Container portfolio with the launch of Cefazolin 3 g, offering a new dosage option designed for surgical infection prevention in patients ...
The company is recalling the product because of out-of-specification results for high molecular weight polymers. Braun Medical Inc. (B. Braun) is voluntarily recalling one lot of 2g Ceftazidime for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results